Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa

Adalimumab-induced thrombocytopenia is a rarely occurring condition that may present with hemorrhagic manifestations. This report describes a case of a patient who presented with severe, symptomatic thrombocytopenia while on adalimumab for the treatment of hidradenitis suppurativa. The patient respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Tkrit, Amna, Obada, Zaid, Muqeet, Sara, Cervantes, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164782/
https://www.ncbi.nlm.nih.gov/pubmed/34094734
http://dx.doi.org/10.7759/cureus.14769
_version_ 1783701189069635584
author Al-Tkrit, Amna
Obada, Zaid
Muqeet, Sara
Cervantes, Jose
author_facet Al-Tkrit, Amna
Obada, Zaid
Muqeet, Sara
Cervantes, Jose
author_sort Al-Tkrit, Amna
collection PubMed
description Adalimumab-induced thrombocytopenia is a rarely occurring condition that may present with hemorrhagic manifestations. This report describes a case of a patient who presented with severe, symptomatic thrombocytopenia while on adalimumab for the treatment of hidradenitis suppurativa. The patient responded to treatment with steroids, intravenous immunoglobulin (IVIG), and platelet transfusion, in addition to discontinuation of adalimumab.
format Online
Article
Text
id pubmed-8164782
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-81647822021-06-03 Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa Al-Tkrit, Amna Obada, Zaid Muqeet, Sara Cervantes, Jose Cureus Hematology Adalimumab-induced thrombocytopenia is a rarely occurring condition that may present with hemorrhagic manifestations. This report describes a case of a patient who presented with severe, symptomatic thrombocytopenia while on adalimumab for the treatment of hidradenitis suppurativa. The patient responded to treatment with steroids, intravenous immunoglobulin (IVIG), and platelet transfusion, in addition to discontinuation of adalimumab. Cureus 2021-04-30 /pmc/articles/PMC8164782/ /pubmed/34094734 http://dx.doi.org/10.7759/cureus.14769 Text en Copyright © 2021, Al-Tkrit et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Hematology
Al-Tkrit, Amna
Obada, Zaid
Muqeet, Sara
Cervantes, Jose
Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa
title Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa
title_full Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa
title_fullStr Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa
title_full_unstemmed Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa
title_short Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa
title_sort adalimumab-induced thrombocytopenia in a patient with hidradenitis suppurativa
topic Hematology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164782/
https://www.ncbi.nlm.nih.gov/pubmed/34094734
http://dx.doi.org/10.7759/cureus.14769
work_keys_str_mv AT altkritamna adalimumabinducedthrombocytopeniainapatientwithhidradenitissuppurativa
AT obadazaid adalimumabinducedthrombocytopeniainapatientwithhidradenitissuppurativa
AT muqeetsara adalimumabinducedthrombocytopeniainapatientwithhidradenitissuppurativa
AT cervantesjose adalimumabinducedthrombocytopeniainapatientwithhidradenitissuppurativa

Ejemplares similares